Prospective Multicenter Cohort Study of Peginterferon, Ribavirin and Telaprevir for Chronic Hepatitis C

Prospective Multicenter Cohort Study of Peginterferon, Ribavirin and Telaprevir for Chronic Hepatitis C - SMART-C V2

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007198

Enrollment

750

Registered

2012-02-01

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic Hepatitis C with Serogroup 1 HCV-RNA >= 5.0 logIU/mL Those who have the indication for peginterferon, ribavirin and telaprevir combination therapy

Exclusion criteria

Exclusion criteria: Not specified

Design outcomes

Primary

Measure	Time frame
Sustained virologic response	—

Secondary

Measure	Time frame
Safety	—

Countries

Japan

Contacts

Public ContactTatsuya Minami

The University of Tokyo Hospital Department of Gastroenterology

tminami-tky@umin.ac.jp03-3815-5411

Outcome results